Skip to main content

Waiving patents for Covid vaccines won't solve the 'need of the hour,' says Indian drugmaker

The world faces an urgent need to vaccinate people, and waiving intellectual property rights doesn't address that problem, according to Umang Vohra of Cipla.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.